Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Kedudukan dalam Saham #39565
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Harga Saham
$0.003084
Modal Pasaran
$434.03K
Perubahan (1 hari)
-7.14%
Perubahan (1 tahun)
-89.24%
Negara
BE
Perdagangan Oxurion N.V. (OXUR)

Kategori

Sejarah harga saham bagi Oxurion N.V. (OXUR)
Harga penutupan tertinggi: $0.00 pada 2026-08-01

Harga penutupan terendah: $62.97K pada 2006-07-01
Sejarah harga saham Oxurion N.V. dari 2006 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$517.18 32.51%
US
$857.76 31.47%
NL
$734.04 7.47%
CH
$1.07K -6.40%
KR
$257.75 13.87%
BE